About Us
DELFI Diagnostics, Inc. (DELFI Diagnostics) is developing next-generation, blood-based tests that are reliable, accessible and deliver a new way to help detect cancer. Employing advanced machine-learning methods to whole-genome sequencing data, the DELFI ("DNA EvaLuation of Fragments for early Interception") platform is built to address the highest-burden health challenges. DELFI Diagnostics prioritizes solutions that have the potential to save lives on a global scale, including for historically underserved populations. DELFI Diagnostics’ platform relies on fragmentomics – the discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments. FirstLook Lung, for individuals eligible for lung cancer screening, is DELFI Diagnostics’ first laboratory-developed screening test and can be part of routine blood work. FirstLook Lung uses millions of data points to reliably identify individuals who may have cancer detected through low-dose CT, including early stage disease with a negative predictive value of 99.8 percent. This test has not been cleared or approved by the FDA.
In our passionate pursuit to radically improve health outcomes, we serve humanity when we:
Lead with Science, Anchor in Pragmatism: We pioneer life-changing science by ensuring quality, transparency, and rigor at all times. We explore thoughtfully, experiment smartly, and deliver impact with conviction.
Build With & For All: We embrace diverse backgrounds to innovate and achieve together. We are not just building a product - we aim to disrupt the path of cancer for all - no matter geography or socioeconomic class
Put We over I: We are a home for high-performing people. Through teamwork, we build collective intelligence. Each of us wins when those we serve and those who serve with us--win. We show up with empathy, humility, and integrity at every step of the journey.
About the Role
Join our innovative team dedicated to reducing cancer deaths through cutting-edge liquid biopsy diagnostics. As Sr. Research Associate, you will be responsible for performing functional quality control testing of incoming GMP-grade reagents, preparing manufacturing controls, and supporting our CLIA-certified laboratory operations. You will work with molecular and biochemical assays, utilizing automated liquid handling systems to ensure our manufacturing processes meet stringent quality standards. Additionally, you will support research and development activities as needed, contributing to method optimization and validation studies.
This contract position requires strong attention to detail and the ability to work in a regulated GMP/CLIA environment where precision and documentation are critical.
An equal opportunity employerWe are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
If an employer mentions a salary or salary range on their job, we display it as an "Employer Estimate". If a job has no salary data, Rise displays an estimate if available.
Lead assay development and assay verification activities for DELFI's NGS-based liquid biopsy platform, executing end-to-end molecular workflows in a fast-paced, highly collaborative laboratory.
Lead assay development and assay verification activities for DELFI's NGS-based liquid biopsy platform, executing end-to-end molecular workflows in a fast-paced, highly collaborative laboratory.
Lead and grow Neuralink's pathology organization to deliver rapid, high-quality preclinical tissue analysis and regulatory-grade pathology insight supporting device development.
Work with engineers, physicians, and KOLs at Intuitive to define clinical performance goals and lead preclinical and early clinical development of novel focal therapy robotic technologies.
An R&D Test Engineering intern at Commonwealth Fusion Systems will help design, build, commission, and run test stands and experiments to generate actionable data for magnet technology development.
Delfi Diagnostics detects cancer early, when it is most curable, using high-precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients. The com...
2 jobs